Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529-Reference-Cited by-同舟云学术

Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529

Published:2017-08-21 Issue:10 Volume:13 Page:1115-1122
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Pancera Marie,Lai Yen-Ting,Bylund Tatsiana,Druz Aliaksandr,Narpala Sandeep,O'Dell Sijy,Schön Arne,Bailer Robert T,Chuang Gwo-Yu,Geng Hui,Louder Mark K^ORCID,Rawi Reda,Soumana Djade I,Finzi Andrés,Herschhorn Alon,Madani Navid,Sodroski Joseph,Freire Ernesto,Langley David R,Mascola John R,McDermott Adrian B,Kwong Peter D

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/nchembio.2460.pdf

Reference60 articles.

1. Lima, V.D. et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 21, 685–692 (2007).

2. Marcus, J.L. et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J. Acquir. Immune Defic. Syndr. 73, 39–46 (2016).

3. Vittinghoff, E. et al. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J. Infect. Dis. 179, 717–720 (1999).

4. Kwon, Y.D. et al. Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat. Struct. Mol. Biol. 22, 522–531 (2015).

5. Wyatt, R. & Sodroski, J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280, 1884–1888 (1998).

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA-based HIV-1 vaccines;Clinical Microbiology Reviews;2024-09-12

2. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

3. The sensitivity of HIV-1 gp120 polymorphs to inhibition by temsavir correlates to temsavir binding on-rate;Antiviral Research;2024-09

4. Inflammatory Biomarker Reduction With Fostemsavir Over 96 Weeks in Heavily Treatment-Experienced Adults With Multidrug-Resistant HIV-1 in the BRIGHTE Study;Open Forum Infectious Diseases;2024-08-26

5. Characterization of clinical envelopes with lack of sensitivity to the HIV-1 inhibitors temsavir and ibalizumab;Antiviral Research;2024-08